Relationship Between the SER Treatment Period and Prognosis of Patients with Small Cell Lung Cancer

Xiao, Xiao-Guang; Wang, Shu-Jing; Hu, Li-Ya; Chu, Qian; Wei, Yao; Li, Yang; Mei, Qi; Chen, Yuan

추천

검색

자료유형: 학술저널

저자정보: Xiao, Xiao-Guang (Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology) Wang, Shu-Jing (Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology) Hu, Li-Ya (Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology) Chu, Qian (Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology) Wei, Yao (Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology) Li, Yang (Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology) Mei, Qi (Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology) Chen, Yuan (Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제15호

발행연도: 2014.1

수록면: 6,415 - 6,419 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Purpose: To explore the relationship between SER (time between the start of any treatment and the end of radiation therapy) and the survival of patients with limited-stage small cell lung cancer. Materials and Methods: Between 2008 and 2013, 135 cases of limited-stage small cell lung cancer (LS-SCLC) treated with consecutively curative chemoradiotherapy were included in this retrospective analysis. In terms of SER, patients were divided into early radiotherapy group (SER<30 days, n=76) and late radiotherapy group ($SER{\geq}30$ days, n=59) with a cut-off of SER 30 days. Outcomes of the two groups were compared for overall survival. Results: For all analyzable patients, median follow-up time was 23.8 months and median overall survival time was 16.8 months. Although there was no significant differences in distant metastasis free survival between the two groups, patients in early radiotherapy group had a significantly better PFS (p=0.003) and OS (p=0.000). Conclusions: A short SER may be a good prognostic factor for LD-SCLC patients treated with concurrent chemoradiotherapy.

#Small cell lung cancer #retrospective study #prognosis #treatment period

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Xiao, Xiao-Guang

소속기관 Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science an